C57BL/6 mice pretreated with IL-18 and IL-2 developed mucosal mastocytosis and had high levels of serum mMCP1 (mouse mast cell protease 1), an activation marker of mucosal mast cells. This evidence concerns the gene IL2 and mastocytosis.